ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | 0.0% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,000 | -25.0% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $4,000 | -42.9% | 13,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $7,000 | -46.2% | 13,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $13,000 | -27.8% | 13,000 | 0.0% | 0.01% | -33.3% |
| Q2 2021 | $18,000 | -18.2% | 13,000 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $22,000 | +29.4% | 13,000 | -3.0% | 0.01% | +20.0% |
| Q4 2020 | $17,000 | -45.2% | 13,400 | -38.8% | 0.01% | -56.5% |
| Q3 2020 | $31,000 | -22.5% | 21,900 | -34.4% | 0.02% | -30.3% |
| Q2 2020 | $40,000 | +2.6% | 33,400 | 0.0% | 0.03% | -71.1% |
| Q1 2020 | $39,000 | +2.6% | 33,400 | +85.6% | 0.11% | +132.7% |
| Q4 2019 | $38,000 | – | 18,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |